Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
AI Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
AI Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
inhaled drug delivery
Pharma
Quince, now IRulya, debuts new name, focus and leadership
The name change follows Quince’s May merger with pulmonary biotech and LAM-001 developer Orphai Therapeutics.
Donavyn Coffey
Oct 9, 2026 11:05am
United's Tyvaso backs up case for IPF expansion with ph. 3 win
Mar 30, 2026 3:06pm
Avalyn adds $100M to advance inhaled versions of IPF pills
Jul 22, 2025 10:44am
Savara's lung disease asset hit with FDA refuse-to-file letter
May 27, 2025 10:35am
AZ pads data package for Airsupra in patients with milder asthma
Oct 7, 2024 2:40pm
Drugmakers dig in their heels amid FTC's latest patent crackdown
Jun 25, 2024 9:20am
